NAVIDEA BIOPHARMACEUTICALS, INC. 4
4 · NAVIDEA BIOPHARMACEUTICALS, INC. · Filed Jan 11, 2017
Insider Transaction Report
Form 4
Greene Mark I
Director
Transactions
- Award
Common Stock
2017-01-10$0.64/sh+16,406$10,500→ 57,244 total
Footnotes (1)
- [F1]Acquired from Issuer in lieu of cash compensation for board services during the fourth quarter of 2016.